Commentary

Podcast

CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection

On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.

On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega. We discussed CMS's recent Medicare Part D and Medicare Advantage final rule and how it affects enrollees and health plans.

The final rule includes various measures, such as the requirements for health equity analysis and behavioral health provider inclusion. It also prioritizes access to accurate information for Medicare enrollees, mandates evidence-based supplemental benefits, and promotes biosimilar substitution.

Listen above or on one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify


Related Videos
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Marla Black Morgan, MD, Phoebe Neurology Associates
Elizabeth Grush, MBA
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Erin Weber, MS
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Dr Johnie Rose
Joseph Saseen, PharmD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo